Arthritis Center Grand RoundsView this program LIVE
|
| Familial Mediterranean Fever Eric C. Muller, MD, Fellow, Section of Rheumatology,Department of Medicine, University of Arizona Disclosure: Presentation will include discussion of unlabeled/investigational drug use. |
||
| Candidate Seminar Systemic Lupus Erythematosus: a Paradigm for Immune-mediated Inflammation & Organ Damage Joseph Ahern , MD, UCLA |
||
| Candidate Seminar Systemic Lupus Erythematosus: a Paradigm for Immune-mediated Inflammation & Organ Damage Ram Singh, MD, UCLA |
||
| B Cell Targeted Therapies in SLE Jennifer H. Anolik, MD, PhD, University of Rochester, Rochester, New York Disclosure: Presenter has an affiliation/financial interest. Presentation includes unlabeled/investigational drug use. |
||
| Candidate Seminar Rheumatoid Arthritis: Disease Spectrum Joseph Holoschitz, MD |
||
| Low Back Pain: Pathophysiology, Natural History and Conservatiive Treatment Ronald Wisneski, MD, University of Arizona Disclosure: Presenter has nothing to disclose |
||
| Candidate Seminar Manipulation of Adaptive Immunity in Pediatric Rheumatology Salvatore Albani, MD, PhD, UCSD |
||
| Journal Club
Eric Mueller, MD, Fellow, Section of Rheumatology, Department of Medicine, University of Arizona Disclosure: Dr. Mueller has nothing to disclose. James O. Posever, MD, Assistant Professor of Clinical Medicine, Director of IHS Rheumatology Services, University of Arizona Disclosure: Dr. Posever has affiliations/financial interests. |
||
| Candidate Seminar Rheumatoid Inflammation: Metabolic Consequences and Implications for Health Outcomes Joan M. Bathon, MD, Director, Johns Hopkins Arthritis Center |
||
| Rheumatic Manifestations of Viral Illness Leonard Calabrese, MD, College of Medicine, Case Western Reserve University |
||
| Osteonecrosis: Dead On! Eric P. Gall, MD, MACP, MACR Professor and Chairman, Department of Medicine, Chicago Medical School, Chief, Division of Rheumatology & Immunology, Professor, Microbiology, Rosalind Franklin University Medicine and Science, Chicago, Illinois| Disclosure: Dr. Gall has nothing to disclose |
||
March 16, 2007
|
The Role of the Rank/Rank-Ligand/OPG Pathway in Bone Loss and Associated Diseases Nancy E. Lane, MD, UC-Davis |
|
Journal Club |
||
March 02, 2007 |
Not published at request of the presenter. | |
February 23, 2007
|
Immunology 101 |
|
February 16, 2007
|
Update on the Pathogenosis and Treatment of Spondyloarthropathies |
|
February 9, 2007
|
Journal Club Recombinant Human Anti-Transforming Growth Factor b1 Antibody Therapy in Systemic Sclerosis Kyaw (Joe) Swe, MD Disclosure: Dr. Swe has no affiliations to disclose Initial Clinical Trial of Epratuzumab (humanized anti-CD22 antibody) for Immunotherapy of Systemic Lupus Erythematosus B. Austin Vaz, MD Disclosure: Dr. Vaz has affiliations/financial interest to disclose: Grant/Research Support – Biogen, Bristol Myers Squibb, Biogen, Centocor, Genentech, NIH, Pfizer, Roche; Consultant – Abbott; Speaker’s Bureau – Abbott. |
|
| Interstitial Lung Diseases in Rheumatic Diseases Kyaw (Joe) Swe Disclosure: Nothing to disclose. |
||
Clinical Radiographic Outcomes of Four Different Treatment Strategies in Patients with Rheumatoid Arthritis Eric C. Mueller, MD, Rheumatology Fellow, The University of Arizona Disclosure: Dr. Mueller has nothing to disclose. Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture Jeffrey R. Lisse, MD Disclosure: Dr. Lisse recieves research/grant support, is a consultant and on a speakers bureau. |
||
| The Technique & Added Value of Ultra Sound in the Diagnosis of Rheumatoid Arthritis Mihra Taljanvic, M.D. Disclosure: Nothing to disclose. |
||
| Journal Club James Posever, M.D. Noe R. Olvera, M.D. Disclosure: Dr. Olvera has nothing to disclose. Dr. Posever has financial interests, arrangements or affiliations with several organizations. |
||
Antiphospholipid Syndrome |
||
| ACR Review Gail Riggs, MA, CHES Eric Mueller, M.D. Shelley Kasle, Ph.D. Disclosure: Presenters have nothing to disclose |
||
| Fibromyalgia: Controversies for the Rheumatologist Don L. Goldenberg, M.D., Chief, Rheumatology, Newton-Wellesley Hospital, Professor of Medicine, Tufts University School of Medicine Disclosure: Nothing to disclose |
||
| Journal Club Jeffrey R. Lisse, M.D. Eric C. Mueller, M.D. Disclosure: Nothing to disclose |
||
| Bone Biology Michael Maracic, MD, Catalina Pointe, Arthritis & Rheumatology Specialists, PC Disclosure: Presenter receives grant/research support, is a consultant, and is on the speakers' bureau for several corporate organizations No Audio for the first ten minutes. |
||
| Core Curriculum Lecture Series: Ankylosing Spondylitis Lisa Sumner, M.D., Rheumatology Program Director, Phoenix Area Disclosure: Nothing to disclose |
||
| Journal Club Noe R. Olvera, M.D., Rheumatology Fellow, University of Arizona Shelley Kasle, Ph.D. Disclosure: Neither presenters have anything to disclose |
||
| Core Curriculum: Osteoarthritis James Posever, M.D. Disclosure: Presenter receives grant/research support, is a consultant, and is on the speakers' bureau for several corporate organizations |
||
| Emerging Strategies in RA Management W. Winn Chatham, M.D. Disclosure: Presentation will include discussion of unlabeled/investigationa drug use. Presenter recieves grant/research support; is a consultant and is on a speakers bureau. |
||
| Obesity and Musculoskeletal Disorders Michele M. Hooper, MD, MS Disclosure: Non-CME |
||
| Journal Club Miranda K. Adelman, PhD Disclosure: Grant/Research Support: ABRC, Southwestern Clinic and Research Center Kyaw (Joe) Swe, MD Disclosure: Nothing to disclose |
||
July 28, 2006
|
Developments in the Pathophysiology of Rheumatoid Arthritis Gregg Silverman, MD; University of California, San Diego Disclosure: Non-CME |
|
| Core Curriculum: Rheumatoid Arthritis B. Austin Vaz, MD Disclosure: Grant/Research support: Biogen, Pfizer, Roche, Genentech, Bristol-Myer Squibb, Genelabs, Human Genome Services, Winston Labs, HIH Knee and Gait studies. Speaker/consultant: Abbott |
||
| Journal Club Lupus Nephritis Eric C. Mueller, MD Disclosure: Nothing to disclose Cyclophosphamide versus Placebo in Scleroderma Lung Disease James Posever, MD Disclosure: Grant/Research Support: Genentech, Immunopedics/UCB, J&J; Consultant: Actelion, Encysivc; Speakers' Bureau: Pfizer, Actelion, Encysivc |
||
| Systemic Lupus Erythematosus Jeffrey R. Lisse, MD (no audio 80 sec) Disclosure: Grant/Research support: Centocor, P&G; Consultant: P&G; Speakers' Bureau: P&G, Eli Lilly, Centocor, Abbott, Amgen, Pfizer |
||